Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4 USD | +0,50 % |
|
-3,85 % | -14,89 % |
11/06 | El consejero delegado de MaxCyte, Maher Masoud, compra 100.000 acciones | AN |
11/06 | Insider de Maxcyte compró acciones por valor de 489.066 dólares, según un reciente registro de la SEC | MT |
Resumen de negocios
Número de empleados: 143
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell Therapy
55,3
%
| 31 | 69,0 % | 23 | 55,3 % | -25,26 % |
Program-related
27,8
%
| 5 | 10,4 % | 11 | 27,8 % | +148,38 % |
Drug Discovery
16,9
%
| 9 | 20,6 % | 7 | 16,9 % | -23,14 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 44 | 100,0 % | 41 | 100,0 % | -6,72 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 27/03/23 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
Corporate Officer/Principal | - | 21/08/23 | |
Gene Zhu
LAW | General Counsel | - | - |
Jill Mayer
HRO | Human Resources Officer | - | 01/01/18 |
Thomas Ross
SAM | Sales & Marketing | 63 | 15/10/14 |
Steven Nardi
PRN | Corporate Officer/Principal | - | 13/10/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 01/12/22 |
Art Mandell
BRD | Director/Board Member | 71 | 01/05/06 |
Will Brooke
BRD | Director/Board Member | 68 | 01/03/04 |
Stanley Erck
BRD | Director/Board Member | 76 | 01/01/05 |
Ron Holtz
ADM | Chief Administrative Officer | 66 | 01/01/05 |
John Johnston
BRD | Director/Board Member | 65 | 01/01/16 |
Richard Douglas
CHM | Chairman | 71 | 12/02/18 |
Yasir Al-Wakeel
BRD | Director/Board Member | 42 | 15/06/21 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 15/06/21 |
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 104 544 289 | 97 857 767 ( 93,60 %) | 0 | 93,60 % |
Información de la empresa
![Dirección MaxCyte, Inc.(MXCT)](https://cdn.zonebourse.com/static/address/120797722.png)
Sector
Ventas por actividad
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,77 % | 210 mil M | |
+8,83 % | 186 mil M | |
+31,94 % | 158 mil M | |
+33,19 % | 113 mil M | |
+5,25 % | 66,13 mil M | |
+22,41 % | 56,25 mil M | |
+1,34 % | 49 mil M | |
-5,92 % | 38,16 mil M | |
+1,94 % | 35,98 mil M |
- Bolsa de valores
- Acciones
- Acción MXCT
- Acción MXCT
- Empresa MaxCyte, Inc.